CVSI (CV Sciences) Short-Term Debt : $0.74 Mil (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is CV Sciences Short-Term Debt?

CV Sciences's Short-Term Debt for the quarter that ended in Sep. 2024 was $0.74 Mil.

CV Sciences's quarterly Short-Term Debt declined from Mar. 2024 ($0.12 Mil) to Jun. 2024 ($0.03 Mil) but then increased from Jun. 2024 ($0.03 Mil) to Sep. 2024 ($0.74 Mil).

CV Sciences's annual Short-Term Debt increased from Dec. 2021 ($0.92 Mil) to Dec. 2022 ($1.22 Mil) but then declined from Dec. 2022 ($1.22 Mil) to Dec. 2023 ($0.25 Mil).

CV Sciences Short-Term Debt Historical Data

The historical data trend for CV Sciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences Short-Term Debt Chart

CV Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

2.17

0.92

1.22

0.25

CV Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															-	0.25	0.12	0.03	0.74

CV Sciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

CV Sciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of CV Sciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CV Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126

Website

https://www.cvsciences.com

CV Sciences Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The Company sells its products under tradenames, such as +PlusCBD and PlusCBD Pet. The Company's products are sold in a variety of market sectors including nutraceutical, beauty care, and specialty foods. The company's hemp-based products are predominantly sold in North America and primarily in the retail space. The company generates revenue from Retail Sales and E-Commerce sales of its product.

Executives

William Mccorkle	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr.	director	9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md	director	2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake	director	145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay	officer: Sr VP Scientific/Regulatory	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling	officer: Chief Financial Officer	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser	officer: CFO	2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham	director	C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty	director	C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin	director	1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc.	other: Member 10% holding group	6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118